Michael Joseph Golembiewski - 31 Aug 2023 Form 4 Insider Report for SEELOS THERAPEUTICS, INC.

Role
Chief Financial Officer
Signature
/s/ Michael Golembiewski
Issuer symbol
N/A
Transactions as of
31 Aug 2023
Net transactions value
+$7,725
Form type
4
Filing time
01 Sep 2023, 16:15:08 UTC
Previous filing
31 Mar 2023
Next filing
01 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SEEL Common Stock Award $7,725 +12,500 +14% $0.6180 103,487 31 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Company's 2020 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).